The improvement of the circulation produced by digitalis in patients with auricular fibrillation is almost invariably associated with slowing of ventricular rate. Whether the improvement is the cause of the slowing, or the result of it, or in part a cause and in part a result of the slowing are matters concerning which opinion is divided. The extent to which the slowing causes the improvement could be established if the slowing could be prevented. It appeared that this problem might be attacked by the use of repeated doses of atropine to prevent the cardiac slowing over a period of several days after a massive dose of digitalis. The influence of digitalis on the heart failure as measured by changes in body weight, fluid loss, and subjective symptoms in these cases might then be compared with its well-known effect in patients in whom the rate is permitted to become slow.
The improvement of the circulation produced by digitalis in patients with auricular fibrillation is almost invariably associated with slowing of ventricular rate. Whether the improvement is the cause of the slowing, or the result of it, or in part a cause and in part a result of the slowing are matters concerning which opinion is divided. The extent to which the slowing causes the improvement could be established if the slowing could be prevented. It appeared that this problem might be attacked by the use of repeated doses of atropine to prevent the cardiac slowing over a period of several days after a massive dose of digitalis. The influence of digitalis on the heart failure as measured by changes in body weight, fluid loss, and subjective symptoms in these cases might then be compared with its well-known effect in patients in whom the rate is permitted to become slow.
The effect of atropine on the heart rate of digitalized patients with auricular fibrillation has been the subject of several reports in the literature, and while views were not entirely in agreement, there seemed to be sufficient accord to indicate that with adequate doses of atropine little difficulty would be encountered in maintaining a rapid heart rate after large doses of digitalis in a considerable proportion of the patients.
A study was planned to pursue this matter, but the original objective ceased to appear promising after several results were obtained, for they showed what was confirmed by subsequent observations, that the experiment could not be carried out, that atropine, even in doses causing severe systemic symptoms, could not prevent the pronounced slowing of the ventricle after very large doses of digitalis. The inference we drew from the literature, therefore, proved to be incorrect, and a reexamination of the literature disclosed the fact that the discordant observations and conflicting conclusions concerning the role of the vagus could not be harmonized by existing data alone.
LITERATURE
While there are numerous reports on the effect of atropine on the ventricular rate which has been slowed by digitalis, the studies of Cushny, Marris, and Silberberg (1) , and Lewis, Drury, Wedd, and Iliescu (2) present the more detailed analyses of the subject. Cushny et al. (1) concluded that "in auricular fibrillation, digitalis and its allies slow the heart from some direct action on the heart and not from stimulation of the inhibitory mechanism, for atropine does not restore the original rate of the released heart." About 10 years later, Lewis et al. (2) , on the other hand, concluded that the ventricular slowing caused by digitalis is in part due to a direct action on the ventricle and in part to vagal stimulation, and that the different proportions of these actions in different cases were chiefly matters of individual variation, both actions being exerted " in different proportions from case to case." In the 10 digitalized patients of 
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"the longer the drug acts the less the role played by the vagus, and the greater that of direct impairment of the A-V fibers."
In his monograph, Robinson (4) called attention to the prevailing uncertainty as to whether the action of digitalis on conduction "should be regarded mainly as an effect of vagus stimulation or as an effect produced by the direct action of the drug on the heart." More recently (5) Elsie Porter reported some new experiments on subjects with auricular fibrillation from which she took the position that the cardiac slowing is entirely vagal, and that " if and when a larger dose of atropin can be safely given intravenously, the whole digitalis effect will be found to fall upon the vagus."
In view of the unsettled state of the matter, our experiments were extended to explore further the effect of maximum doses of atropine on the heart rate in auricular fibrillation after various doses of digitalis in one and the same individual, in different individuals, and under different conditions. The results of these are presented in the present report.
METHOD
Patients. The experiments were performed on 9 subjects with organic heart disease. In 8 of these there was an advanced degree of heart failure with congestion, and in 1 there were no signs or symptoms of heart failure. All had a persistent auricular fibrillation. The characteristics of the group are summarized in Table I . The patients were admitted to the hospital and kept in bed. In addition to the routine laboratory tests, includ- insufficiency, enlarged heart; developed auricular fibrillation after hemorrhoidectomy while in the hospital; had had thyroidectomy 18 years ago for exophthalmic goiter, but now has a normal metabolic rate * All had advanced congestive heart failure, except this patient who never had signs or symptoms of failure.
ing electrocardiograms and the daily clinical examinations, their fluid intake and output, and ventricular and pulse rates were charted. They were weighed on admission and again usually every third day. The fluid intake was fixed at approximately a liter a day. The control period was continued until a fairly fixed level was reached for ventricular rate, body weight, and water balance. The control period lasted up to 16 days, but was terminated as early as 3 days after admission in 3 cases in which the heart failure appeared to be growing rapidly worse. During the control period digitalis and diuretics were withheld.
Digitalis. The drug was administered in the form of compressed tablets of the powdered leaf standardized by the cat method. All but Case 9 received digitalis with a potency of 97 mgm. per cat unit. A dose of 0.14 to 0.2 cat unit per pound of body weight (24 to 54 grains) was given at one time in 6 cases; in 4 of these, additional doses were given subsequently. Two cases received smaller doses at the start, but a total of 0.14 and 0.46 cat unit per pound in 2 and 13 days respectively. These doses were sufficient to induce toxic symptoms in 4 of the 9 patients (Table II) . In calculating the dose, no allowance was made for the amount of edema fluid. Case 9 received a specimen of digitalis with a cat unit potency of 85 mgm.
Atropine. Enough atropine was given to abolish completely the vagal control of the ventricular rate. The dose which appeared sufficient to accomplish this was 2,io grain (2.16 mgm.) of atropine sulfate by intravenous injection, as shown by the fact that the release of the heart rate produced by this dose was in no instance increased by more of the drug (tested in 6 experiments). In all, 36 intravenous doses of atropine sulfate were administered in a concentration of 0.2 per cent in physiological salt solution. These (1 dose). In one case a total of 2A4 grain (6 mgm.) was given in 2 hours and in another a total of % grain (13 mgm.) was given in 24 hours. As already indicated, the maximum effect on the rate resulted from Y,4o grain, and larger doses served merely to intensify the toxic symptoms. These doses are substantially similar to those found necessary to obtain maximum ventricular release in experiments by Lewis, Drury, Wedd, and Iliescu (2).
The ventricular rate was counted with the stethoscope at the apex, a count of a half minute being taken at intervals of 1 to 2 minutes at first, and then at longer intervals. In one case the rate was counted on electrocardiograms taken at similar intervals. The maximum acceleration of the rate was in evidence within a minute or two. Partial recovery, however, occurred fairly rapidly; as much as a half of the acceleration might disappear within about 15 minutes. The complete return of the rate to the pre-atropine level after the dose of 2,fo grain was more gradual, sometimes not quite complete even after about 5 or 6 hours. Some delay in the return may be due to restlessness induced by the atropine. It Figure 4 shows that it is not a matter of individual peculiarity, for in the same individual the slow heart rate during digitalis action may be at one time under vagal control and at another time under extravagal control. For example, in Case 2, the control is extravagal 10 hours after 42 grains of digitalis; it is the vagal type (100 per cent release) after 4 days, but it again returns to the extravagal control (only 16 per cent release) on the fourteenth day. Similarly, in Case 3, the heart rate is slow by a vagal mechanism on the first and second day after the digitalis, but by a predominantly extravagal mechanism on the tenth and eleventh day. In Table II are summarized the observations in all the experiments indicating that one and the same individual may show both types of control. Figure 5 shows that the mechanism which will control the slow heart rate after digitalis is not directly related to the degree of heart failure. In Case 5, the same mechanism, the extravagal one, which controlled the ventricular rate during the period in which the symptoms of failure had almost completely subsided (loss of 12 pounds of edema fluid) on the eighth day after beginning digitalis, was already in control 8 hours after the first massive dose of 35 grains, when relatively little clinical improvement was in evidence. In Case 2, the extravagal mechanism predominated in the slowing about 8 hours after 42 grains of digitalis, as shown by the fact that even though the vagi were blocked by atropine the rate did not exceed 104 (reduced from 145). During this period very little clinical improvement was in evidence. By the fourth day marked clinical improvement had taken place, the patient having lost 10 pounds of edema fluid. At this time the control had shifted to the vagal mechanism (rate after atropine release, 161). Figure 6 shows that the two mechanisms may be seen at different times in a patient without signs or symptoms of heart failure.
The foregoing results show that the vagal and extravagal types of control of the ventricular rate may alternate in the course of digitalization in a manner that seems in no way related to the state of the myocardial function as revealed by the clinical signs and symptoms.
In Table II , the effect of the size of the dose on the mechanism is shown. The dose of digitalis appears to be the only factor consistently related to the mechanism. It is not safe to compare one case with another with respect to the amounts of drug because of differences in tolerance, but the course of events in individual cases shows that when the dose is increased the atropine test reveals a shift from the vagal to the extravagal control of the ventricular rate, and vice versa, when the dose acting upon the heart is reduced. For example, in Case 1, a predominantly vagal type (Case Al, 100 per cent release) 2 hours after the dose of digitalis, became a predominantly extravagal type (Case Bi, 23 per cent release) after more digitalis had been absorbed in 23 hours following its administration. In Case 2, there is the extravagal type of control 8 hours after the large dose of digitalis (see also Figure 5 ), the (Lewis) , and 68 (present study). Slow rate, therefore, was no indication of the mechanism by which the slowing was caused, for in one group with this slow rate atropine abolished the slowing completely and in the other the effect of atropine was relatively slight. This matter will be considered in another communication.
SUMMARY AND CONCLUSIONS
1. There is no general agreement regarding the r6le of the vagus in the ventricular slowing by digitalis, some maintaining that the drug acts mainly on conduction directly, and others, that its action is mediated chiefly or wholly through the vagus.
2. In the present investigation on patients with auricular fibrillation we found, as others have, that paralytic doses of atropine always cause some acceleration of the ventricle which has been slowed by digitalis, and that this effect varies from slight acceleration to complete abolition of the slowing.
3. We have observed, however, that if the doses of digitalis are large enough, atropine cannot prevent digitalis from producing marked slowing of a rapid ventricle (to 100 a minute or slower).
4. In digitalized patients with auricular fibrillation, the Ventricle is maintained at a slow rate usually by the summation of two factors: one, a vagal factor (abolished by atropine) and two, an extravagal factor (not abolished by atropine).
5. In the average case, the vagal factor predominates in the slowing of the ventricle after moderate doses of digitalis, while the extravagal factor predominates after large doses.
6. Which of the two factors (vagal or extravagal) will dominate in the control of the slowed heart rate depends, therefore, upon the degree of digitalization. Contrary to statements found in the literature, our results show that it is not a matter of individual peculiarity, the degree of heart failure, or the length of time the heart has been under the influence of digitalis.
7. The discordant views in the literature regarding the r6le of the vagus, and the factors which alter its r6le, in slowing of the ventricle in auricular fibrillation arise from the failure to make adequate observations on the effect of maximum doses of atropine after different doses of digitalis in one and the same subject.
